Article citationsMore>>

M. R. Benz, J. Czernin, S. M. Dry, W. D. Tap, M. S. Allen-Auerbach, D. Elashoff, M. E. Phelps, W. A. Weber and F. C. Eilber, “Quantitative F18-Fluorodeoxyglucose Positron Emission Tomography Accurately Characterizes Peripheral Nerve Sheath Tumors as Malignant or Benign,” Cancer, Vol. 116, No. 2, 2010, pp. 451-458. doi:10.1002/cncr.24755

has been cited by the following article:

• TITLE: Malignant Triton Tumor in the Abdominal Wall: A Case Report

  AUTHORS: Yoshiyuki Kitamura, Koichiro Abe, Shingo Baba, Takuro Isoda, Yasuhiro Maruoka, Yoshio Matsuo, Yuichiro Kubo, Akio Sakamoto, Hiroshi Nishimura, Masayuki Sasaki, Hiroshi Honda

  KEYWORDS: Malignant Triton Tumor (MTT); Malignant Peripheral Nerve Sheath Tumor (MPNST); 2-[F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

  JOURNAL NAME: Advances in Molecular Imaging, Vol.3 No.2, April 12, 2013

  ABSTRACT: Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor (MPNST) with rhabdomyosarcomatous differentiation. We report the case of a 54-year-old male without a history of neurofibromatosis type 1 (NF1) who had a growing abdominal wall tumor diagnosed as MTT. Computed tomography (CT), magnetic resonance imaging (MRI) and 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography/CT (FDG-PET/CT) were performed. The MRI and FDG-PET/CT indicated that the lateral component of the tumor was composed of many proliferative cells, corresponding to the histopathological finding of a cellular proliferation of spindle-shaped cells. In light of this case and previous reports, it is apparent that FDG-PET/CT is a helpful tool for distinguishing MTT from benign peripheral nerve sheath tumor.